Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$2.97 -0.10 (-3.26%)
As of: Oct 21, 2026 · 10:32 AM EDT

Galmed Pharmaceuticals (EOCN) EBIT Margin (2016 - 2023)

Updated

Galmed Pharmaceuticals (EOCN) recorded EBIT Margin of 525.76% in FY2018, down 613.78 percentage points from 1139.54% in FY2017.

Analysis

Galmed Pharmaceuticals (EOCN) EBIT Margin (2016 - 2023) Analysis & Trends

  • Per Business Quant data, EOCN's EBIT Margin was 1139.54% in FY2017 (-2475.45 pp) and 3614.99% in FY2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,131.65 Bn 1,100.24 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 615.89 Bn 534.41 Bn 17.26 Bn 28.21%
3 AbbVie 505.03 Bn 478.14 Bn 12.70 Bn 37.86%
4 Merck 368.78 Bn 323.16 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.66 Bn 262.65 Bn 11.24 Bn 32.97%
6 Astrazeneca 262.09 Bn 235.78 Bn 12.86 Bn 20.57%
7 Amgen 236.57 Bn 191.97 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.05 Bn 165.25 Bn 6.22 Bn -133.21%
9 Pfizer 170.60 Bn 117.25 Bn 10.94 Bn 28.37%
10 Galmed Pharmaceuticals 1.60 Mn -39.09 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -294.00%
Mar 31, 2022 -277.78%
Sep 30, 2018 78.67%
Jun 30, 2018 -994.44%
Mar 31, 2018 954.85%
Dec 31, 2017 -7,694.89%
Sep 30, 2017 1,009.16%
Jun 30, 2017 -997.04%
Mar 31, 2017 1,217.91%
Dec 31, 2016 1,734.67%
Sep 30, 2016 1,971.50%
API Access

Galmed Pharmaceuticals EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=EOCN&period=max&api_key=YOUR_API_KEY